Dendritic cells and acute graft-versus-host disease after allogeneic stem cell transplantation

References

• Billingham R E. The biology of graft-versus-host reactions. Harvey Lect 1966; 62: 21–78
   PubMedGoogle Scholar
• Sackstein R. A revision of Billingham's tenets: the central role of lymphocyte migration in acute graft-versus-host disease. Biol Blood Marrow Transplant 2006; 12: 2–8
   PubMed Web of Science ®Google Scholar
• Holler E, Kolb H J, Moller A, Kempeni J, Liesenfeld S, Pechumer H, et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 1990; 75: 1011–1016
   PubMed Web of Science ®Google Scholar
• Ferrara J L, Reddy P. Pathophysiology of graft-versus-host disease. Semin Hematol 2006; 43: 3–10
   PubMed Web of Science ®Google Scholar
• Holler E, Kolb H J, Mittermuller J, Kaul M, Ledderose G, Duell T, et al. Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F). Blood 1995; 86: 890–899
   PubMed Web of Science ®Google Scholar
• Shlomchik W D, Couzens M S, Tang C B, McNiff J, Robert M E, Liu J, et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999; 285: 412–415
   PubMed Web of Science ®Google Scholar
• Teshima T, Ordemann R, Reddy P, Gagin S, Liu C, Cooke K R, et al. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med 2002; 8: 575–581
   PubMed Web of Science ®Google Scholar
• Matte C C, Liu J, Cormier J, Anderson B E, Athanasiadis I, Jain D, et al. Donor APCs are required for maximal GVHD but not for GVL. Nat Med 2004; 10: 987–992
   PubMed Web of Science ®Google Scholar
• Mapara M Y, Kim Y M, Wang S P, Bronson R, Sachs D H, Sykes M. Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells. Blood 2002; 100: 1903–1909
   PubMed Web of Science ®Google Scholar
• Reddy P, Maeda Y, Liu C, Krijanovski O I, Korngold R, Ferrara J L. A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nat Med 2005; 11: 1244–1249
   PubMed Web of Science ®Google Scholar
• Mapara M Y, Kim Y M, Marx J, Sykes M. Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism. Transplantation 2003; 76: 297–305
   PubMed Web of Science ®Google Scholar
• Ordemann R, Hutchinson R, Friedman J, Burakoff S J, Reddy P, Duffner U, et al. Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease. J Clin Invest 2002; 109: 1249–1256
   PubMed Web of Science ®Google Scholar
• Banchereau J, Steinman R M. Dendritic cells and the control of immunity. Nature 1998; 392: 245–252
   PubMed Web of Science ®Google Scholar
• van Kooyk Y, Geijtenbeek T B. DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol 2003; 3: 697–709
   PubMed Web of Science ®Google Scholar
• Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179: 1109–1118
   PubMed Web of Science ®Google Scholar
• Steinman R M, Hawiger D, Nussenzweig M C. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21: 685–711
   PubMed Web of Science ®Google Scholar
• Liu Y J. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005; 23: 275–306
   PubMed Web of Science ®Google Scholar
• Kuwana M, Kaburaki J, Wright T M, Kawakami Y, Ikeda Y. Induction of antigen-specific human CD4(+) T cell anergy by peripheral blood DC2 precursors. Eur J Immunol 2001; 31: 2547–2557
   PubMed Web of Science ®Google Scholar
• Moseman E A, Liang X, Dawson A J, Panoskaltsis-Mortari A, Krieg A M, Liu Y J, et al. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J Immunol 2004; 173: 4433–4442
   PubMed Web of Science ®Google Scholar
• Gilliet M, Liu Y J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 2002; 195: 695–704
   PubMed Web of Science ®Google Scholar
• Colonna M, Trinchieri G, Liu Y J. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004; 5: 1219–1226
   PubMed Web of Science ®Google Scholar
• Martin P, Del Hoyo G M, Anjuere F, Arias C F, Vargas H H, Fernandez L A, et al. Characterization of a new subpopulation of mouse CD8alpha+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood 2002; 100: 383–390
   PubMed Web of Science ®Google Scholar
• Bilsborough J, George T C, Norment A, Viney J L. Mucosal CD8alpha+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties. Immunology 2003; 108: 481–492
   PubMed Web of Science ®Google Scholar
• de Heer H J, Hammad H, Soullie T, Hijdra D, Vos N, Willart M A, et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 2004; 200: 89–98
   PubMed Web of Science ®Google Scholar
• Mellor A L, Baban B, Chandler P, Marshall B, Jhaver K, Hansen A, et al. Cutting edge: induced indoleamine 2,3-dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J Immunol 2003; 171: 1652–1655
   PubMed Web of Science ®Google Scholar
• Fallarino F, Asselin-Paturel C, Vacca C, Bianchi R, Gizzi S, Fioretti M C, et al. Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J Immunol 2004; 173: 3748–3754
   PubMed Web of Science ®Google Scholar
• Salio M, Palmowski M J, Atzberger A, Hermans I F, Cerundolo V. CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens. J Exp Med 2004; 199: 567–579
   PubMed Web of Science ®Google Scholar
• Schlecht G, Garcia S, Escriou N, Freitas A A, Leclerc C, Dadaglio G. Murine plasmacytoid dendritic cells induce effector/memory CD8+ T-cell responses in vivo after viral stimulation. Blood 2004; 104: 1808–1815
   PubMedGoogle Scholar
• Ochando J C, Homma C, Yang Y, Hidalgo A, Garin A, Tacke F, et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol 2006; 7: 652–662
   PubMed Web of Science ®Google Scholar
• Benitez-Ribas D, Adema G J, Winkels G, Klasen I S, Punt C J, Figdor C G, et al. Plasmacytoid dendritic cells of melanoma patients present exogenous proteins to CD4+ T cells after Fc gamma RII-mediated uptake. J Exp Med 2006; 203: 1629–1635
   PubMed Web of Science ®Google Scholar
• Waller E K, Rosenthal H, Jones T W, Peel J, Lonial S, Langston A, et al. Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation. Blood 2001; 97: 2948–2956
   PubMed Web of Science ®Google Scholar
• Arpinati M, Green C L, Heimfeld S, Heuser J E, Anasetti C. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 2000; 95: 2484–2490
   PubMed Web of Science ®Google Scholar
• Fagnoni F F, Oliviero B, Giorgiani G, De Stefano P, Deho A, Zibera C, et al. Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation. Blood 2004; 104: 281–289
   PubMed Web of Science ®Google Scholar
• Chklovskaia E, Nowbakht P, Nissen C, Gratwohl A, Bargetzi M, Wodnar-Filipowicz A. Reconstitution of dendritic and natural killer-cell subsets after allogeneic stem cell transplantation: effects of endogenous flt3 ligand. Blood 2004; 103: 3860–3868
   PubMed Web of Science ®Google Scholar
• Mohty M, Blaise D, Faucher C, Bardou V J, Gastaut J A, Viens P, et al. Impact of plasmacytoid dendritic cells on outcome after reduced-intensity conditioning allogeneic stem cell transplantation. Leukemia 2005; 19: 1–6
   PubMed Web of Science ®Google Scholar
• Reddy V, Iturraspe J A, Tzolas A C, Meier-Kriesche H U, Schold J, et al. Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease. Blood 2004; 103: 4330–4335
   PubMed Web of Science ®Google Scholar
• Vakkila J, Thomson A W, Hovi L, Vettenranta K, Saarinen-Pihkala U M. Circulating dendritic cell subset levels after allogeneic stem cell transplantation in children correlate with time post transplant and severity of acute graft-versus-host disease. Bone Marrow Transplant 2005; 35: 501–507
   PubMed Web of Science ®Google Scholar
• Arpinati M, Chirumbolo G, Urbini B, Bonifazi F, Bandini G, Saunthararajah Y, et al. Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2004; 10: 106–115
   PubMed Web of Science ®Google Scholar
• Kitawaki T, Kadowaki N, Ishikawa T, Ichinohe T, Uchiyama T. Compromised recovery of natural interferon-alpha/beta-producing cells after allogeneic hematopoietic stem cell transplantation complicated by acute graft-versus-host disease and glucocorticoid administration. Bone Marrow Transplant 2003; 32: 187–194
   PubMed Web of Science ®Google Scholar
• Clark F J, Freeman L, Dzionek A, Schmitz J, McMullan D, Simpson P, et al. Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host disease. Transplantation 2003; 75: 221–225
   PubMed Web of Science ®Google Scholar
• Lau J, Sartor M, Bradstock K F, Vuckovic S, Munster D J, Hart D N. Activated circulating dendritic cells after hematopoietic stem cell transplantation predict acute graft-versus-host disease. Transplantation 2007; 83: 839–846
   PubMed Web of Science ®Google Scholar
• Collin M P, Hart D N, Jackson G H, Cook G, Cavet J, Mackinnon S, et al. The fate of human Langerhans cells in hematopoietic stem cell transplantation. J Exp Med 2006; 203: 27–33
   PubMed Web of Science ®Google Scholar